Figure 9: A forest plot diagram showed one of the adverse events, cataract, in the eyes suffered with RVO-related ME after treatments with anti-VEGF agents and DEX. The follow-up examinations occurred at 6 months, the endpoint of clinical trial. Data were presented as mean [95% CI]. IV, inverse variance
![Figure 9: A forest plot diagram showed one of the adverse events, cataract, in the eyes suffered with RVO-related ME after treatments with anti-VEGF agents and DEX. The follow-up examinations occurred at 6 months, the endpoint of clinical trial. Data were presented as mean [95% CI]. IV, inverse variance](articles/2019/67/11/images/IndianJOphthalmol_2019_67_11_1800_269632_f9.jpg)